JamesThomasKalmukMD

PubMed

• 2 citations
  An overview of the preclinical discovery and development of trastuzumab deruxtecan: a novel gastric cancer therapeutic.
  James Kalmuk, Dan Rinder, Carl Heltzel, Albert Craig Lockhart> ;Expert Opinion on Drug Discovery. 2022 May 1
• 2 citations
  Clinical utility of chromosomal microarray in establishing clonality and high risk features in patients with Richter transformation.
  Brian T. Hess, James Kalmuk, Iya Znoyko, Cynthia A. Schandl, Nina D. Wagner-Johnston, Sandra Mazzoni, Lindsey Hendrickson, Zane Chiad, Irl Brian Greenwell, Daynna J. W...> ;Cancer Genetics. 2022 Jan 1
• 18 citations
  Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge
  James Kalmuk, Jon Puchalla, Gong Feng, Anshu Giri, John M. Kaczmar> ;Cancers of the Head & Neck. 2020 Feb 3
• 6 citations
  Parvovirus B19-induced hemophagocytic lymphohistiocytosis: Case report and review of the literature.
  James Kalmuk, Sara Matar, Gong Feng, Edward Kilb, Ming Y. Lim> ;Clinical Case Reports. 2019 Sep 27
• 16 citations
  Multimodal imaging guided preclinical trials of vascular targeting in prostate cancer.
  James Kalmuk, Margaret R. Folaron, Julian Buchinger, Roberto Pili, Mukund Seshadri> ;Oncotarget. 2015 Jul 3
• 14 citations
  Vascular priming enhances chemotherapeutic efficacy against head and neck cancer
  Margaret R. Folaron, James Kalmuk, Jaimee Lockwood, Costakis Frangou, Jordan Vokes, Steven G. Turowski, Mihai Merzianu, Nestor R. Rigual, Maureen Sullivan-Nasca, Moni ...> ;Oral Oncology. 2013 Sep 1
• Join now to see all

Lectures

• Clinical Utility of Chromosomal Microarray in Establishing Clonality and High Risk Features in Patients with Richter Transformation 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019